Further to envisage the putative clinical applications of orthogonal IL-2/IL-2R pairs, the efficacy of tumor-specific orthoIL-2Rβ T cells in the B16-F10 mouse model of melanoma was determined. This evidence concerns the gene IL2RA and neoplasm.